Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in VYGR — Voyager Therapeutics, Inc.

CIK 873630 LONDON, X0
Back to VYGR Full portfolio

Position in VYGR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$116,207
-$11,952 QoQ
Shares Held
33,202
0.0% QoQ
Ownership
0.054%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 135 holders
Holding Since
Dec 2023
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VYGR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. VYGR ranks #113 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 676,247 $335,912,169
2 REGN
Regeneron Pharmaceuticals, Inc.
 382,028 $238,209,735
3 INCY
Incyte Corp
 1,307,743 $148,245,744
4 RPRX
Royalty Pharma plc
 1,224,925 $68,681,542
5 MRNA
Moderna, Inc.
 636,199 $44,553,014
6 ALNY
Alnylam Pharmaceuticals, Inc.
 115,279 $34,702,435
7 INSM
INSMED Inc
 279,961 $29,849,438
8 BMRN
Biomarin Pharmaceutical Inc
 307,543 $17,597,610

All Filings in VYGR

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $116,207 33,202
2026-03-31 $128,159 33,202
2025-12-31 $206,859 52,636
2025-09-30 $691,416 148,055
2025-06-30 $461,452 148,377
2025-03-31 $229,512 67,903
2024-12-31 $221,271 39,025
2024-09-30 $215,806 36,890
2024-06-30 $128,458 16,240
2023-12-31 $120,877 14,322